Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease-Modifying Therapy-Reference-Cited by-同舟云学术

Risks of Herpes Zoster in Patients With Rheumatoid Arthritis According to Biologic Disease-Modifying Therapy

Published:2015-04-24 Issue:5 Volume:67 Page:731-736
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care & Research

Author:

Yun Huifeng¹,Xie Fenglong¹,Delzell Elizabeth¹,Chen Lang¹,Levitan Emily B.¹,Lewis James D.²,Saag Kenneth G.¹,Beukelman Timothy¹,Winthrop Kevin³,Baddley John W.¹,Curtis Jeffrey R.¹

Affiliation:

1. University of Alabama at Birmingham

2. University of Pennsylvania; Philadelphia

3. Oregon Health and Science University; Portland

Funder

Agency for Healthcare Research and Quality

Publisher

Wiley

Subject

Rheumatology

Reference20 articles.

1. Clinical practice: herpes zoster;Cohen;N Engl J Med,2013

2. Risk of herpes zoster in patients with rheumatoid arthritis treated with anti-TNF-α agents;Strangfeld;JAMA,2009

3. Health care utilization and cost burden of herpes zoster in a community population;Yawn;Mayo Clin Proc,2009

4. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction;Yawn;Mayo Clin Proc,2007

5. Clinical practice: herpes zoster;Gnann;N Engl J Med,2002

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Applications of Biological Therapy for Latent Infections: Benefits and Risks;International Journal of Molecular Sciences;2024-08-24

2. The use of biological and targeted synthetic basic anti-inflammatory drugs in elderly patients with rheumatoid arthritis: for or against;Problems of Geroscience;2024-06-30

3. Exploring the Link between Varicella-Zoster Virus, Autoimmune Diseases, and the Role of Recombinant Zoster Vaccine;Biomolecules;2024-06-22

4. Increased Risk of Herpes Zoster in Rheumatoid Arthritis Not Only Due to JAK Inhibitors—Study of 392 Patients from Single University Center;Journal of Clinical Medicine;2024-05-26

5. Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs;RMD Open;2024-02